Shares of Anbio Biotechnology (NNNN) surged 10% to $5.50 in intraday trading on Wednesday, outperforming the broader market.
The biotech company's stock price rallied after making a successful debut on the Nasdaq exchange, with its shares opening at $5.26, higher than the $5 initial public offering price. This strong investor demand signals optimism surrounding Anbio's prospects as a newly public company.